Simultaneous PET/MRI with 13C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification by Adam E. Hansen et al.
ORIGINAL RESEARCH Open Access




Adam E. Hansen1*, Flemming L. Andersen1, Sarah T. Henriksen1,2, Alexandre Vignaud3, Jan H. Ardenkjaer-Larsen2,
Liselotte Højgaard1, Andreas Kjaer1 and Thomas L. Klausen1
* Correspondence:
adam.espe.hansen@regionh.dk
1Department of Clinical Physiology,




Full list of author information is
available at the end of the article
Abstract
Background: Integrated PET/MRI with hyperpolarized 13C magnetic resonance
spectroscopic imaging (13C-MRSI) offers simultaneous, dual-modality metabolic
imaging. A prerequisite for the use of simultaneous imaging is the absence of
interference between the two modalities. This has been documented for a clinical
whole-body system using simultaneous 1H-MRI and PET but never for 13C-MRSI and
PET. Here, the feasibility of simultaneous PET and 13C-MRSI as well as hyperpolarized
13C-MRSI in an integrated whole-body PET/MRI hybrid scanner is evaluated using
phantom experiments.
Methods: Combined PET and 13C-MRSI phantoms including a NEMA [18F]-FDG
phantom, 13C-acetate and 13C-urea sources, and hyperpolarized 13C-pyruvate were
imaged repeatedly with PET and/or 13C-MRSI. Measurements evaluated for
interference effects included PET activity values in the largest sphere and a
background region; total number of PET trues; and 13C-MRSI signal-to-noise ratio
(SNR) for urea and acetate phantoms. Differences between measurement conditions
were evaluated using t tests.
Results: PET and 13C-MRSI data acquisition could be performed simultaneously
without any discernible artifacts. The average difference in PET activity between
acquisitions with and without simultaneous 13C-MRSI was 0.83 (largest sphere) and
−0.76 % (background). The average difference in net trues was −0.01 %. The average
difference in 13C-MRSI SNR between acquisitions with and without simultaneous PET
ranged from −2.28 to 1.21 % for all phantoms and measurement conditions. No
differences were significant. The system was capable of 13C-MRSI of hyperpolarized
13C-pyruvate.
Conclusions: Simultaneous PET and 13C-MRSI in an integrated whole-body PET/MRI
hybrid scanner is feasible. Phantom experiments showed that possible interference
effects introduced by acquiring data from the two modalities simultaneously are
small and non-significant. Further experiments can now investigate the benefits of
simultaneous PET and hyperpolarized 13C-MRI in vivo studies.
Keywords: PET/MRI, 13C magnetic resonance spectroscopic imaging, Hyperpolarization,
Quantification, Interference
EJNMMI Physics
© 2016 Hansen et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made.
Hansen et al. EJNMMI Physics  (2016) 3:7 
DOI 10.1186/s40658-016-0143-6
Background
Integrated PET/MRI offers the combination of functional imaging of positron emis-
sion tomography (PET) and high soft-tissue contrast of anatomic magnetic resonance
imaging (MRI) in a simultaneous acquisition. Clinical MRI is for the major part based
on 1H nuclei, which are predominantly present in water. 1H-MRI has also functional
capabilities, for instance to measure perfusion, characterize tissue cellularity through
diffusion-weighted MRI, and study metabolites with magnetic resonance spectroscopy
(MRS). The use of MRS imaging (MRSI) is, however, in general challenged by the low
sensitivity of in vivo MRI.
Hyperpolarized MRI offers a signal increase by many orders of magnitude. Recently,
the feasibility of using a 13C-labeled pyruvate substrate, hyperpolarized through the
dynamic nuclear polarization method [1], for imaging of tumor metabolism in man was
demonstrated [2]. Hence metabolic imaging based on 13C-MRSI has come within the
reach of routine clinical use.
PET is an established clinical method for metabolic imaging. For example, in oncol-
ogy, the tracer 18F-2-fluoro-2-deoxy-D-glucose (FDG) gives a measure of glucose
metabolism. Since both 13C-MRSI and FDG-PET are metabolic imaging techniques,
comparison studies are highly relevant [3] and have been pursued using sequential
13C-MRSI and PET [4, 5]. In the setting of integrated PET/MRI, simultaneous
hyperpolarized 13C-MRSI and PET could become a reality. Such a setup could be
very important for generation of new knowledge in physiology and pathophysiology
as well as demonstrating potential clinical benefits of 13C-MRSI.
A prerequisite for the use of simultaneous PET and MRI is the absence of interfer-
ence between the two systems for reviews; see, e.g., [6–8]. Absence of interference
has been documented for a clinical whole-body system using simultaneous 1H-MRI
and PET [9] but never for 13C-MRS(I) and PET. Radio frequency (RF) electromag-
netic radiation, which is both transmitted and picked up by MRI coils, is a well-
known potential source of interference both from MRI to PET and vice versa [7]. PET
systems based on solid-state photodetectors have a major part of the electronics
placed in close proximity to the MRI RF system. To avoid cross-talk, PET electronics
is shielded by a conducting material [10–16]. The shielding material can induce eddy
currents and magnetic field inhomogeneities, and the thickness of the material must
therefore be minimized [11]; e.g., for a human brain PET insert, a 10-μm copper
shield was used [15]. The magnetic resonance frequency is approximately four times
lower for 13C than that for 1H due to the lower gyromagnetic ratio. Shielding effi-
ciency depends on the square root of the frequency of the electromagnetic radiation
and can be characterized by a penetration depth. Therefore, shielding optimized for
1H-MRI may not be similarly efficient for 13C-MRSI. Apart from shielding effects,
also the magnetic field gradients employed for spatial encoding can potentially intro-
duce noise in the PET measurement system [7]. Due to the lower gyromagnetic ratio,
the amplitude of the imaging gradients may be increased. The lower 13C resonance
frequency and as well the corresponding need for higher imaging gradients imply
that performance measurements for simultaneous 1H-MR(S)I and PET cannot be dir-
ectly translated to simultaneous 13C-MRSI and PET.
Thus, the aim of the present work is to demonstrate the feasibility of simultaneous
PET and 13C-MRSI in an integrated whole-body PET/MRI hybrid scanner. Phantom
Hansen et al. EJNMMI Physics  (2016) 3:7 Page 2 of 13
experiments were carried out to investigate if simultaneous 13C-MRSI and PET
acquisition is possible without influencing the PET and 13C-MRSI quantification.




Combined PET and MRI were performed using an integrated PET/MRI system (Sie-
mens Biograph mMR, Erlangen, Germany).
The phantom setups employed are shown in Figs. 1 and 2. An overview of all mea-
surements is shown in Table 1. The PET performance (Fig. 1) was evaluated using a
body-mimicking phantom (PTW, Freiburg, Germany) which is part of image quality
tests according to the standard of the National Electrical Manufacturers Association
(NEMA). The background part of the NEMA phantom was filled with demineralized
water with added NaCl (5 g/L) and NiSO4 (3.75 g/L) for improving MR image quality
compared to pure water [8]. A set of hollow spheres was filled with an aqueous solution
of [18F]-FDG (40.11 kBq/mL). The background had an activity of 5.18 kBq/mL. Activities
were measured by a well counter.
1H-MRI utilized the built-in RF body coil. 13C-MRI utilized a transmit/receive 12-
cm loop coil (RAPID Biomedical, Würzburg, Germany) placed on top of the NEMA
phantom. Inside the loop coil were placed two 5.5-mL vials of 4.0 M [13C]urea and
4.0 M [1-13C]acetate doped with gadolinium (Dotarem®) (0.23 %, v/v). The vials were
centered vertically above the set of hollow spheres. A cardboard holder above the
loop coil was used to place a syringe with hyperpolarized [1-13C]pyruvate.
For later alignment with CT data, a total of six fish oil capsules were placed at vari-
ous positions at the phantom.
The 13C-MRSI performance was mainly evaluated using the phantom setup shown
in Fig. 2. A cylindrical phantom supplied as a part of the PET/MRI system (mMR
water, 9.5 L volume) was filled with demineralized water added an aqueous solution
of [18F]-FDG (16.2 kBq/mL). The 12-cm loop coil was placed on top of the mMR
water phantom, with the urea and acetate vials inside the loop.
Fig. 1 NEMA phantom setup. a Photo of setup with PET NEMA phantom and pyruvate syringe for
hyperpolarized 13C-MRSI marked with arrows. b 1H-MRI with urea and acetate vials for thermally polarized
13C-MRSI marked with arrows. c CT with cross section of 13C loop coil marked with arrows
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PET/MR data acquisition, NEMA phantom
The NEMA phantom (Fig. 1) was placed on the patient table with the set of
hollow spheres in the isocenter of the scanner. Only the hardware described above
was present.
Following localizer scans, first, a calibration of the 13C MR flip angle was performed
using the urea vial. A series of free induction decay measurements with increasing
transmitter voltage was acquired (repetition time (TR) 10,000 ms, echo time (TE)
0.35 ms, (nominal) flip angle 90°, pulse duration 0.50 ms, bandwidth 3000 Hz, transmit-
ter voltage 10 to 90 V in steps of 10 V). Chemical shift spectra were centered on the
[13C]urea peak. A sinusoidal fit of the [13C]urea peak height versus transmitter voltage
was used to determine the relation between transmitter voltage and flip angle.
To evaluate the effect of simultaneous 13C-MRSI on the PET, a total of 16 PET list
mode acquisitions were performed (1 bed position). During PET acquisitions with scan
numbers 1, 3, 5, 7, 9, 11, 13, and 15, simultaneous 13C-MRSI was carried out; the
remaining PET acquisitions were MR silent. The PET acquisition time was 6 min for
Fig. 2 mMR water phantom setup. a Photo of setup with mMR water phantom. The 13C loop coil is
marked with arrows. b 1H-MRI with urea and acetate vials marked with arrows







FDG activity Phantom Comparisons
1, 3, 5, 7, 9,
11, 13, 15
ON ON ON 34–16 MBq NEMA PET, 13C-MRSI acq. ON versus
OFF
2, 4, 6, 8, 10,
12, 14, 16
OFF ON ON
17–20, 25–28 ON OFF ON 41–31 MBq mMR
water
13C-MRSI, PET gantry ON versus
OFF; with high activity
21–24 ON OFF OFF
29–32, 37–40 ON OFF ON 0.21–0.18 MBq 13C-MRSI, PET gantry ON versus
OFF; with low activity
33–36 ON OFF OFF
Scan numbers are consecutive in time. The total FDG activity of the phantom is given at the start and end of each
measurement series (1–16, 17–28, and 29–40, respectively)
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scan numbers 1–8 and 8 min for scan numbers 9–16, to (partially) compensate for the
decay of the tracer. During the first 58 s of each PET acquisition, vendor-supplied
Dixon-VIBE MRI intended for MR attenuation correction (MRAC) was performed.
For 13C-MRSI, a chemical shift imaging (CSI) sequence was used (TR 130 ms, TE
2.3 ms, flip angle 29°, bandwidth 4000 Hz, 1024 points in spectrum, field-of-view
200 mm, voxel size 12.5 × 12.5 × 23.0 mm3). The sequence used a 16 × 16 grid and
elliptical k-space sampling. Chemical shift spectra were centered on the [13C]urea peak.
The CSI sampling time was 19 s and was repeated for the remainder of the PET
acquisition following the Dixon MRI.
After the 13C-MRSI and PET acquisitions, a 1H-MRI VIBE sequence (TR 4.18 ms,
TE 1.6 ms, flip angle 5.0°, bandwidth 540 Hz/pixel, field-of-view 350 mm, voxel size
1.6 × 1.6 × 3.0 mm3) was obtained as a structural reference.
Hyperpolarization experiment
At the end of the PET/MRI NEMA phantom scan session, a hyperpolarization experi-
ment was carried out. Hyperpolarized 13C-pyruvate was produced using the SpinLab
system (GE Healthcare, Milwaukee, WI, USA). The sample consisted of [1-13C]pyruvic
acid mixed with an electron paramagnetic agent (sample concentration 15 mM) manu-
factured by Syncom (Groningen, Netherlands, PN AH111501) under contract from
General Electric. The dissolution media applied contained 0.1 g/L ethylenediaminetet-
raacetic acid disodium salt dehydrate (EDTA disodium salt, Sigma PN E4994) in water,
and the neutralization media used to neutralize the hyperpolarized [1-13C]pyruvic acid
sample prior to injection contained 0.72 M NaOH, 0.4 M Tris, and 0.1 g/L EDTA diso-
dium salt in water. A 60-mL syringe with hyperpolarized 13C-pyruvate was placed in
the abovementioned holder. Imaging took place immediately hereafter using the above
CSI sequence with the flip angle reduced to 1°.
CT data acquisition
Following the PET/MR NEMA phantom scan session, a CT (Siemens Biograph mCT)
scan of the NEMA phantom including the coil was performed. The phantom was cen-
tered as in the PET/MR. The low-dose CT (120 kVp, 3-mm slices) scan was used for
CT-based attenuation correction (CTAC).
PET reconstruction
PET images of the NEMA phantom from both the PET and MR were reconstructed
using vendor-supplied 3D OP-OSEM with 4 iterations, 21 subsets, and a 4-mm Gauss-
ian filter. Voxel size was 2.08 × 2.08 × 2.03 mm3 with matrix 344.
For PET/MR CTAC, the low-dose CT image was used. First, the PET/CT patient
table was manually removed using OsiriX (v. 4.1.2, Pixmeo, Geneva, Switzerland). CT
images were subsequently aligned with the MR VIBE images using Minc (minctracc,
McConnell Imaging Center, Montreal), whereupon the Hounsfield units were con-
verted to linear attenuation coefficients using the bi-linear scaling of Carney et al. [17]
as implemented in our PET/CT systems. The patient bed of the PET/MR is automatic-
ally included in the AC map by the vendor-supplied algorithm. No additional hardware
elements were present during the PET/MR scan session. The first minute of the PET
Hansen et al. EJNMMI Physics  (2016) 3:7 Page 5 of 13
acquisition (during which simultaneous Dixon MRI was performed) was excluded from
all reconstructions to study the possible effect of 13C-MRSI only.
PET/MR data acquisition, mMR water phantom
The mMR phantom setup (Fig. 2) was placed on the patient table with the 13C loop coil
in the isocenter of the scanner. A calibration of the 13C MR flip angle was performed
using the urea vial with the same procedure as above.
To evaluate the effect of the PET data acquisition system on the 13C-MRSI, 13C-MRSI
was performed with the PET gantry in an “ON” or “OFF” state. With the PET gantry in
the OFF state, all PET electronics inside the Faraday cage of the PET/MRI examination
room are switched off. This procedure can be accessed through the service module of the
system. A total of 24 13C-MRSI acquisitions were performed. During acquisitions with
scan numbers 17–20 and 25–28, the PET gantry was ON; during acquisitions with scan
numbers 21–24, the PET gantry was OFF. The ON-OFF-ON design was chosen as a slight
temporal drift of the 13C-MRSI urea peak height was noted during preparation of the
measurements. The ON-OFF-ON set of measurements was repeated 14 h later when the
activity of the phantom had decayed to less than 1 % of its initial value. Please refer to
Table 1 for an overview of measurements.
For 13C-MRSI, the above CSI sequence was used again (one repetition only). A 1H-
MRI VIBE sequence with parameters as above was obtained as a structural reference.
Evaluation of PET quantification
We report the average PET activity value (kBq/mL) of a spherical VOI with a diam-
eter of 20 mm, centrally placed in the largest sphere (with an inside diameter of
37 mm). Background activity was measured using a spherical VOI with a diameter of
60 mm, placed in the center of the phantom. PET activity was decay corrected to the
time of the filling of the phantom. In addition, the total number of trues for each PET
acquisition on the PET/MR system was obtained from the list mode files (total
prompts subtracted total randoms) and corrected for decay and the differences in
acquisition times.
Percent differences between PET acquisitions obtained with 13C-MRSI active (ON) or
not (OFF) were calculated using the 13C-MRSI OFF condition as the reference. Differ-
ences were evaluated using a two-sample t test.
Evaluation of 13C-MRSI quantification
Peak heights of [1-13C]acetate, [13C]urea, and [1-13C]pyruvate (hyperpolarized experi-
ment only) were quantified for every MRSI voxel using a general linear model imple-
mented in MATLAB (MathWorks, Natick, MA, USA). The estimation was performed
in the time domain. Metabolite maps were interpolated on a 128 × 128 grid for visual
presentation.
The 13C-MRSI noise was derived from the background part of the 13C spectrum
(from −2000 to −1000 Hz and from 1000 to 2000 Hz) in voxel (1,1) at the corner of
the 13C-MRSI grid, far from the 13C phantoms, which was verified to have no signal.
The noise was estimated as the standard deviation of the real part of the signal,
multiplied by the square root of the number of repetitions of the MRSI. 13C-MRSI
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signal-to-noise ratio (SNR) was estimated for urea and acetate using the voxel with
maximum signal. The signal was defined as the integrated peak area [18] in an inter-
val of ±250 Hz around the peak.
Percent differences of SNR between 13C-MRSI acquisitions for the mMR water phan-
tom obtained with PET gantry “ON” or “OFF” were calculated using the OFF condition
as the reference. Differences were evaluated using a two-sample t test. Differences were
evaluated both with and without high activity in the gantry (see Table 1).
Statistical evaluation
Data are reported with 95 % confidence intervals (CI), and a p value of 0.05 was consid-
ered significant.
Results
On a general note, PET and 13C-MRSI data acquisition could be performed simultan-
eously without any practical issues.
PET quality
As an example of PET quality, reconstructed transverse images from scan numbers 1
(13C-MRSI “ON”) and 2 (13C-MRSI “OFF”) are shown in Fig. 3. Line plots of average
activity during 13C-MRSI ON and OFF conditions are shown in Fig. 4. No artifacts
from the simultaneous 13C-MRSI acquisition were discerned. However, both back-
ground profiles show a peak towards the center. Figure 5 shows PET activity in the
largest sphere and the background for all 16 PET acquisitions. There was no visible
time dependence or dependence on whether the 13C-MRSI was ON or OFF.
The results are summarized in Table 2. The average difference in PET activity be-
tween acquisitions with 13C-MRSI ON and OFF was 0.83 (largest sphere) and
−0.76 % (background). The differences were not significant (p = 0.18, CI (−0.42 to
2.07 %) and p = 0.16, CI (−1.85 to 0.33 %)) for the largest sphere and background,
respectively. The average difference in net trues was −0.01 % and was not signifi-
cant (p = 0.97, CI (−0.38 to 0.37 %)).
Fig. 3 Examples of PET during 13C-MRSI ON and OFF. PET with a simultaneous 13C-MRSI (scan number 1)
and b without any MRI performed (scan number 2)
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13C-MRSI quality
Figure 6 shows [13C]urea and [1-13C]acetate SNR for 13C-MRSI acquisitions using the
mMR water phantom. There was no apparent dependence on whether the PET gantry
was OFF or ON, neither in the condition with PET activity high (Fig. 6a) nor low
(Fig. 6b). However, a tendency to an overall temporal drift can be noticed in Fig. 6b.
The average difference in SNR between acquisitions with high PET activity and PET
gantry ON versus OFF was 1.21 % and was not significant (p = 0.31, CI (−1.27 to
3.67 %)) for [13C]urea and was 1.15 % and not significant (p = 0.29, CI (−1.13 to
3.42 %)) for [1-13C]acetate. The average difference in SNR between acquisitions with
low PET activity and PET gantry ON versus OFF was −2.03 % and was not significant
Fig. 4 PET profiles during 13C-MRSI ON and OFF. PET line plots of voxels between the black lines of the
inserts, through a the largest sphere (single slice) and b background region (10 slices). Conditions of
simultaneous 13C-MRSI ON and OFF are shown as red and blue colors, respectively
Fig. 5 PET activity for all NEMA phantom measurements. Measured PET activity in the largest sphere (blue
points) and in a background region of the phantom (black points). Error bars are standard deviations on
estimates. For odd PET scan numbers, simultaneous 13C-MRSI was performed, as indicated by the
yellow bars
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(p = 0.21, CI (−5.51 to 1.38 %)) for [1-13C]urea and was −2.28 % and not significant
(p = 0.15, CI (−5.61 to 0.98 %)) for [1-13C]acetate. Further examination of the data re-
vealed that neither noise level nor integrated peak areas were significantly different
between PET gantry OFF and ON conditions.
In Fig. 7, we show examples of the 13C-MRSI obtained with the mMR water phantom
with (scan number 17) and without (scan number 21) the PET gantry switched on. No
artifacts from the PET electronics were discerned. Figure 8 shows examples of 13C
spectra zoomed on the [13C]urea peak. The only visible difference between PET gantry
ON and OFF conditions is a small drift in peak position.
Finally, in Fig. 9 (lower right), we show an example of hyperpolarized 13C-MRSI with
[1-13C]pyruvate.
Discussion
The presented phantom data demonstrates that simultaneous PET and 13C-MRSI in a
whole-body PET/MRI scanner is possible. Interference effects introduced by acquiring
data from the two modalities simultaneously are small and non-significant. Hence, full
advantage can be taken of the integrated PET/MRI scanner design. Furthermore, the
integrated PET/MRI system was proven capable of hyperpolarized 13C-MRSI.
A simultaneous acquisition of PET and 13C-MRSI will reduce total examination time
and minimize subject motion between the imaging modalities, which is likely to be
beneficial for in vivo studies. Also, functional imaging can be performed without a delay
between the modalities, thus ensuring that the physiologic state of the subject is un-
changed. This is particularly desirable when 13C-MRSI is combined with PET tracers
Table 2 Summary of PET measurements
13C-MRSI ON (n = 8) 13C-MRSI OFF (n = 8)
PET activity, largest sphere 37.62 ± 0.49 kBq/mL 37.31 ± 0.38 kBq/mL
PET activity, background 6.02 ± 0.04 kBq/mL 6.06 ± 0.08 kBq/mL
Net trues 208,943 ± 723 208,959 ± 747
Measurements are performed on PET/MR with and without simultaneous 13C-MRSI
Fig. 6 13C-MRSI SNR for mMR water phantom measurements. Plots show urea (blue symbols) and acetate
(red symbols) SNR for 13C-MRSI scan numbers 17 to 40. For scan numbers 21–24 and 33–36, the PET gantry
was switched off, as indicated by the yellow bar. The PET activity was high and low for scan numbers 17–28
(a) and scan numbers 29–40 (b), respectively
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Fig. 7 Examples of 13C-MRSI during PET gantry ON and OFF. 13C-MRSI obtained with the PET gantry
OFF (left column) and with the PET gantry ON (right column). Top row is acetate, bottom row urea
metabolite images
Fig. 8 Examples of 13C spectroscopy during PET gantry ON and OFF. Plots show 13C spectra under
conditions of the PET gantry ON and OFF, as denoted in the legend. Spectra are from the voxel with the
maximum urea signal and zoomed on the urea peak to highlight the small differences of the spectra
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using a short uptake time and in cases where a pharmacological challenge or another
intervention is employed.
The PET results presented here using a standard quality assurance phantom shows
no effect of simultaneous 13C-MRSI (Figs. 3 and 4). The statistical analysis of our
repeated measurements (Fig. 5) allows us to conclude that the maximum possible
quantitative PET estimation error due to interference from the 13C-MRSI is below 2 %
(95 % CI). That can be considered a sufficiently low error for clinical and research
purposes.
The CSI sequence used to test interference with PET is a typical type of sequence for
hyperpolarized MRSI. The RF flip angle was set to 29°, corresponding to the Ernst
angle for a typical tissue longitudinal MR relaxation time (T1) of 1000 ms, giving a
maximum signal for a thermal polarization. In case of hyperpolarized MRI, most often
a lower flip angle is chosen (e.g., 10° in Ref. [2]) to preserve the hyperpolarization as
long as possible. Hence in practice, possible interference effects caused by RF radiation
will be smaller than in the present experiment.
When MRI is not performed, no RF radiation is transmitted and the magnetic field is
constant. Conversely, there is no fundamental change of state of the PET detector
system between situations where imaging data is collected or not. A possible RF
interference from the PET detector system to the 13C-MRSI would depend on the PET
gantry being powered on or off. However, no effect of power state is observed (Figs. 6,
7, and 8). The maximum 13C-MRSI SNR error due to PET gantry power state is below
−6 to +4 % (95 % CI) for all measurements. A tendency to temporal drift in the
Fig. 9 Examples of 13C-MRSI. 13C-MRSI metabolite images (color, scale bar inserted) overlaid on 1H-MRI
(lower left). upper row: Acetate and urea metabolite images. lower right: Image of hyperpolarized pyruvate
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measurements, seemingly unrelated to the power state (see Fig. 6b), could have inflated
the error estimation. The ON-OFF-ON design of the experiment will compensate for a
linear trend of system instability only. Overall though, a stability of a few percent on
13C-MRSI SNR in a single 19-s acquisition as used here can be considered satisfactory.
The present study was not designed to investigate a hypothetical overall (i.e., PET
acquisition and activity independent) degradation of the 13C-MRSI due to the PET
system. For example, the presence of the PET detector system could degrade the static
magnetic field inhomogeneity; however, this was shown not to be the case for the PET/
MRI system used here by Delso et al. [9]. The focus of the present work was on RF
effects which depend on the gyromagnetic ratio and hence potentially differ from
1H- to 13C-based imaging.
Importantly, the 13C-MRSI quality in this integrated PET/MRI setup was sufficient to
perform metabolic imaging using hyperpolarization in a phantom setting (Fig. 9) and
also recently for in vivo experiments [19, 20].
We noticed an unexpected non-uniform activity in the background region of the
NEMA phantom (Fig. 4b). The non-uniformity could originate from suboptimal
attenuation or scatter correction of the setup and deserves further investigation.
However, the profile appeared to be independent of the 13C-MRSI acquisition. Further
challenges specific to simultaneous PET and 13C-MRSI include characterization and
correction for photon attenuation due to 13C coils. Preliminary investigations at our
institution indicate that this effect can change PET activity values with up to 10 %,
however, without any change in visual interpretation of images.
Conclusions
The present work demonstrated the feasibility of simultaneous PET and 13C-MRSI in
an integrated whole-body PET/MRI hybrid scanner. Phantom experiments showed that
simultaneous 13C-MRSI and FDG-PET acquisition is possible without influencing the
PET quantification. Furthermore, the system is capable of hyperpolarized 13C-MRSI.
Hereby, the way is paved for simultaneous PET and hyperpolarized 13C-MRI in vivo
studies.
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